About.

Contact.

Resources.

For The CEO.

For The HR Executive.

P: (111) 111-1111

E: something@something.com

LIFE SCIENCES PRACTICE

Our Life Sciences team partners with some of the most innovative companies on the planet across Biopharmaceuticals, Medical Device, Diagnostics and Digital Health. Please see below for our specific Practice areas of expertise.

OUR SPECIALTIES

PHYSICIAN LEADERSHIP

BUSINESS/COMMERCIAL LEADERSHIP

FINANCE

REGULATORY/ QUALITY

RESEARCH/ DISCOVERY LEADERSHIP

DIGITAL HEALTH

WE BRING YOU LEADERS

WHO SCALE COMPANIES

CLIENTS & PLACEMENTS

Health Technology Innovation

Alphabet company Verily is developing tools to collect and organize health data, then creating interventions and platforms that put insights derived from that health data to use for more holistic care management for diseases that affect large populations.


Chief Operating Officer
Westwood & Wilshire partnered with Verily and Alphabet management to fill this critical leadership role in one of the world’s most innovative health technology companies.

Clinical Lead

Commercial Launch

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using a proprietary Adhesive Dermally-Applied Microneedle technology. The lead clinical asset has completed the pivotal efficacy trial and is filing for approval in 2020.


Chief Executive Officer
Westwood & Wilshire partnered with Zosano to identify a succession CEO to lead the build out of the commercial infrastructure and launch of the company’s lead asset.

Rare Disease Pharmaceuticals

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes.


Vice President of Medical Services, Global Medical Affairs
Senior Medical Director, Gene Therapy
Senior Medical Director, PegPal
Senior Director, Clinical Biospecimen Management
Medical Director, Achondroplasia
Additional placements:

Director, Immunogenicity
Director, Regulatory Affairs CMC
Medical Director, Drug Safety Surveillance
Director of Regulatory Affairs
Director, Immunogenicity
Director, Business Development
Director of Development Science Quality, TMF, Records Mgmt
Scientist II, NonClinical Pharmacology / Toxicology
Senior Clinical Science Specialist in the Gene Therapy program

Genetic Sequencing, Drug Development

Regeneron is accelerating and improving the traditional drug development process through our proprietary technologies which produce optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.


Therapeutic Area Head, Immunology, Genetics Center
Head, Clinical Trial Operations
Senior Director, Clinical Development
Medical Director, Immunology

MicroRNA Therapies

We are harnessing the power of microRNA science to develop therapies that normalize biological pathways and counterbalance disease.


Senior Vice President, Clinical Science
Senior Vice President, R&D

PLACEMENTS BY SECTOR

MEDICAL/CLINICAL RESEARCH
Chief Medical Officer
Senior Vice President, Clinical
Vice President of Medical Services, Global Medical Affairs
Head of Rare Disease Clinical Development
Head, Clinical Trial Operations
Executive Director, Clinical Development, Oncology
Executive Director, Ophthalmology
Senior Director, Medical Affairs
Senior Medical Director, Clinical Development, Zika
Senior Medical Director, Gene Therapy
Director, US Medical Affairs Oncology
Medical Director, Achondroplasia
REGULATORY & COMPLIANCE
Chief Technology Officer
Executive Vice President, Quality
VP, Head of Global Regulatory Affairs
Medical Director, Drug Safety Surveillance
Director, Regulatory Operations and Compliance – Vaccine BU
Director of Development Science Quality, TMF, Records Management
Regulatory Affairs Lead
COMMERCIAL
Chief Executive Officer
Chief Operations Officer
Chief Commercial Officer
Chief Business Officer
Vice President Corporate Strategy
Senior Director, Business Development